🍁 Golden Autumn, Big Prizes Await!
Gate Square Growth Points Lucky Draw Carnival Round 1️⃣ 3️⃣ Is Now Live!
🎁 Prize pool over $15,000+, iPhone 17 Pro Max, Gate exclusive Merch and more awaits you!
👉 Draw now: https://www.gate.com/activities/pointprize/?now_period=13&refUid=13129053
💡 How to earn more Growth Points for extra chances?
1️⃣ Go to [Square], tap the icon next to your avatar to enter [Community Center]
2️⃣ Complete daily tasks like posting, commenting, liking, and chatting to rack up points!
🍀 100% win rate — you’ll never walk away empty-handed. Try your luck today!
Details: ht
Propanc obtains US patent and plans to purchase 100 million USD worth of Ether to support cancer drug development.
[Coin World] Propanc Biopharma (NASDAQ: PPCB) announced that it has obtained a U.S. patent covering its leading cancer therapy PRP clinical dose, enhancing its intellectual property portfolio, bringing its total global patents to 90. At the same time, this biotech company announced plans to acquire $100 million worth of Ethereum over the next 12 months as part of its digital asset diversification strategy to support clinical development while avoiding excessive equity dilution. This dual strategy draws on financial strategies adopted by some companies, combining patent protection with encryption assets to fund drug development. Propanc plans to launch its phase 1B clinical trial for its enzyme-based solid tumor cancer therapy next year.